Iopidine

Apraclonidine hydrochloride, the active ingredient in Iopidine, is an alpha‑2 adrenergic agonist presented as an ophthalmic solution for ocular use. It reduces intra‑ocular pressure in glaucoma and ocular hypertension, and may be used as adjunctive therapy after ocular surgery.

GNH USA supplies Iopidine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Products are manufactured under GMP conditions and are available for export to multiple regions, including the EU and Asia.

Iopidine, an alpha‑2 adrenergic agonist, is used to lower intra‑ocular pressure in several ocular conditions.

- Glaucoma: reduces intra‑ocular pressure to help prevent optic nerve damage. - Ocular hypertension: lowers pressure to reduce the risk of progression to glaucoma. - Post‑operative ocular surgery: adjunctive therapy to control IOP after procedures.

Apraclonidine ophthalmic solution may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation: transient burning or stinging after drop. - Redness: mild conjunctival hyperemia. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash, or severe eye inflammation. - Cardiovascular effects: hypotension or bradycardia (rare systemic absorption). - Severe ocular inflammation: uveitis or persistent pain.

When using Iopidine, several precautions should be observed to ensure safety and effectiveness.

- Patient assessment: evaluate intra‑ocular pressure and glaucoma status before initiating therapy. - Contraindications: avoid in patients with known hypersensitivity to apraclonidine or other alpha‑2 agonists. - Monitoring: regularly check IOP and ocular health during treatment. - Systemic effects: be aware of possible cardiovascular changes, especially in patients with heart disease. - Drug interactions: review concomitant ocular medications for additive IOP‑lowering effects. - Store at room temperature: keep the solution below 25 °C, in the original container, protected from light and moisture.

Apraclonidine may interact with other medications affecting ocular pressure or systemic adrenergic activity.

Major Interactions (Avoid): - Beta‑blocker eye drops: combined use may cause excessive IOP reduction. - Systemic alpha‑2 agonists (e.g., clonidine): additive hypotensive effects.

Moderate Interactions (Monitor Closely): - Carbonic anhydrase inhibitors: may enhance IOP‑lowering effect. - Topical non‑steroidal anti‑inflammatory drugs: could increase ocular irritation. - Anticholinergic agents: may affect pupil size and ocular comfort.